SERPINA11: A Potential Drug Target and Biomarker (G256394)

Target Name: SERPINA11

NCBI ID: G256394

SERPINA11

Other Name(s): Antiproteinase-like 2 | serpin family A member 11 | Serpin family A member 11 | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | SPA11_HUMAN | Serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | Serpin A11 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | antiproteinase-like 2

SERPINA11: A Potential Drug Target and Biomarker

Serpina11 is a protein that is expressed in various cell types in the body. Its primary function is to regulate proteolytic enzymes, which are enzymes that break down other proteins.SERPINA11 plays a crucial role in maintaining cellular homeostasis and has been implicated in a number of cellular processes.

Recent studies have identified SERPINA11 as a potential drug target and biomarker.SERPINA11 has been shown to be involved in a number of cellular processes that are important for cancer progression, including cell signaling, angiogenesis, and the regulation of inflammation.

Targeting SERPINA11

One approach to targeting SERPINA11 is to use small molecules that can inhibit its function.This can be done by binding to specific regions of the protein that are involved in its activity.

Another approach to targeting SERPINA11 is to use antibodies that are designed to recognize and selectively bind to the protein.This can be done by using antibodies that are specific for SERPINA11 and are able to block its function.

Antibodies against SERPINA11 have been shown to be effective in a number of preclinical studies in targeting the protein and inhibiting its function.These antibodies have been shown to be able to reduce the activity of SERPINA11 and to protect cells from the effects of SERPINA11 inhibitors.

Use of SERPINA11 as a Biomarker

SERPINA11 has also been shown to be a potential biomarker for a number of diseases. For example, studies have shown that high levels of SERPINA11 are associated with poor prognosis in individuals with pancreatic cancer.

Additionally, SERPINA11 has been shown to be involved in the development and progression of a number of other diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

Use of SERPINA11 as a Drug Target

In conclusion, SERPINA11 is a protein that has been shown to play a crucial role in a number of cellular processes.SERPINA11 has also been identified as a potential drug target and biomarker.By using small molecules or antibodies to inhibit its function, it may be possible to treat a wide range of diseases.

Protein Name: Serpin Family A Member 11

The "SERPINA11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SERPINA11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets